Esophageal Cancer Surgery Can Result in Clustered Symptoms
Eating difficulties and reflux/cough symptom clusters are associated with an increased risk of mortality in patients with esophageal cancer.
Eating difficulties and reflux/cough symptom clusters are associated with an increased risk of mortality in patients with esophageal cancer.
Central abdominal adiposity is associated with an increased risk of esophageal inflammation, metaplasia, and adenocarcinoma.
Meta-analysis shows a decreased risk of esophageal adenocarcinoma in patients who engaged in the most physical activity.
Adolescents’ weight and socioeconomic status may affect their subsequent risk of developing esophageal and gastric cancer.
Increased leptin levels and insulin resistance are linked to an increased risk of esophageal adenocarcinoma in patients with Barrett’s esophagus.
The presence of human papillomavirus (HPV) DNA is associated with a three-fold higher risk of esophageal cancer.
Among patients with Barrett’s esophagus who die within 10 years of diagnosis, approximately 2% of deaths are caused by esophageal cancer.
An imaging system no bigger than a multivitamin capsule produces high-resolution images without the need for sedation or training in endoscopy.
Surgeon, but not hospital, volume influences prognosis after esophageal cancer surgery.
Selective organ-sparing surgery after chemoradiation therapy is an effective treatment for patients with nonmetastatic and resectable esophageal cancer, according to findings from the long-term, multicenter phase 2 Radiation Therapy Oncology Group 0246 trial presented during the 10th annual Gastrointestinal Cancers Symposium on January 25th in San Francisco, CA.